Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program.
Two groups totaling 162 patients hospitalized for modified Goeckerman treatment of severe psoriasis were matched for sex, age, and season of admission and followed up for two years after discharge. One group remained hospitalized throughout their average 20.8-day course; the other half was hospitalized 14 days, then transferred to an ambulatory center for the remainder of a course averaging 20.8 days. No difference was detected between the groups in the duration that improvement equaled or exceeded progress achieved at discharge. The percentage of patients remaining continuously improved after discharge was 80% at one month, 55% at six months, 40% at 12 months, and 20% at 24 months. rates of relapse requiring readmission or alternate therapy were also similar: 75% had not relapsed by 12 months and 60% had not relapsed by 24 months.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D010789:Phototherapy / Q000379:methods*; D011565:Psoriasis / Q000628:therapy*; D013638:Tars / Q000008:administration & dosage*
D013638:Tars